Schistosoma

If you've swum, waded, bathed, or worked in fresh water where schistosomiasis occurs, you may have been exposed even if you feel well. Intestinal infections can cause few symptoms, and a microscope exam can miss them when few eggs are passing. Stool qPCR looks for the parasite's DNA and has detected more infections than microscopy in several human studies.

Stool qPCR is used as a diagnostic aid in specialist laboratories, but assays are not standardized across laboratories. Accuracy depends on the species, DNA target, and sample processing. The available test information specifies stool qPCR but doesn't identify the species covered, the DNA target, or whether the report includes a quantity. Results from other assays don't establish the validated performance of this particular test.

What the Test Looks For

Schistosoma is a group of parasitic flatworms called blood flukes. The intestinal species live in blood vessels around the gut. Their eggs pass through the bowel wall into stool, while others become trapped in tissues. Much of the parasite DNA detected in stool comes from eggs.

qPCR stands for quantitative polymerase chain reaction. It copies a selected stretch of DNA repeatedly so that small amounts can be detected. Some assays target one species; others detect several. A result reported as Schistosoma doesn't necessarily identify which species is present.

Stool is the usual specimen for intestinal species such as S. mansoni and S. japonicum. S. haematobium mainly releases eggs into urine. Even an assay that recognizes its DNA may miss urinary infection when run on stool, and some regions have both intestinal and urinary species.

Some qPCR assays provide a cycle threshold (Ct). This is the copying cycle at which the signal crosses the assay's detection threshold. Within the same assay, a lower Ct generally reflects more target DNA. Although Ct has correlated with stool egg counts in research, it doesn't directly count living worms or measure organ damage. Some laboratories report only detected or not detected; those results have no numerical level to trend.

Why Microscopy Can Miss Infections

Kato-Katz is a stool microscopy technique widely used in endemic-area surveys. A technician spreads a small, measured amount of stool on a slide and counts eggs. Routine clinical laboratories may use other preparation methods. Eggs are unevenly distributed and their output varies between days, so light infections are easy to miss. In one low-transmission Brazilian study, statistical modeling estimated that Kato-Katz examination of two slides detected only 38% of infections.

Human studies illustrate the potential advantage of stool qPCR. These comparisons used different assays and should not be read as a single accuracy estimate.

The comparison method also changes the apparent accuracy. In a Brazilian study, qPCR detected about 97% of infections found with 24 Kato-Katz slides, but about 83% when those slides were combined with another method that concentrates eggs. In a small study of imported infections in Spain, one broad Schistosoma qPCR missed several microscopy-positive stool samples, while assays with different DNA targets performed better.

A negative microscopy result can therefore leave an infection undetected, but a negative qPCR can too. Additional positives found by qPCR often reflect infections microscopy missed; contamination and other false-positive results still need consideration when the result doesn't fit your exposure history.

Bowel Damage and Bleeding

Eggs trapped in the bowel wall trigger inflammation. Chronic infection can cause ulcers, clusters of immune cells around eggs, and polyp-like growths. Symptoms can include persistent belly pain, diarrhea, and blood in the stool. Schistosomiasis can also contribute to anemia and impaired growth in children.

These complications are established features of intestinal schistosomiasis. A stool DNA result doesn't establish which symptoms the infection caused or how much tissue damage has occurred.

Liver Scarring and Portal Hypertension

Some eggs are carried from the gut toward the liver in the normal direction of blood flow. They lodge in small vessels, where inflammation can produce scarring around branches of the portal vein. This is called periportal fibrosis.

The scarring can obstruct blood flow and raise pressure in the portal vein. This is portal hypertension. It can enlarge the spleen and produce swollen veins in the esophagus or stomach that may bleed; advanced disease can also cause fluid to collect in the abdomen.

These risks are best documented in people with longstanding or repeated exposure in endemic areas. Studies haven't established that the low-burden infections typical of short-term travelers carry the same risk of liver scarring. Current stool DNA levels cannot predict that risk for you.

Some observational studies have linked previous S. japonicum infection with colorectal cancer. They assessed infection history or tissue findings, not stool qPCR, and their findings shouldn't be generalized to every Schistosoma species or used to estimate cancer risk from this result.

Other Infections and Pregnancy

Some studies have linked schistosomiasis with worse outcomes during other illnesses. They used antibody testing or microscopy, so they describe associations with schistosomiasis without establishing that a stool qPCR result predicts those outcomes.

A Zambian study tested 2,145 people from couples in which one partner had HIV. Women with HIV and schistosome antibodies had about twice the rate of death during follow-up after adjustment for HIV disease stage. Antibodies in partners with HIV were also associated with greater HIV transmission. Antibody positivity could reflect previous as well as current schistosome infection, and the study didn't establish that treating it would reduce HIV transmission or deaths.

Among 174 people treated for tuberculosis in Mali, death occurred in 18.0% of those with S. mansoni eggs in stool and 5.6% of those without them. The association remained after adjustment for other factors, but this was a small observational study in people with tuberculosis, not a mortality estimate for otherwise healthy people with a positive qPCR.

A Nigerian pregnancy study linked heavier infection with worse maternal anemia. It used stool and urine microscopy, and most infections were the urinary species S. haematobium. This doesn't establish stool qPCR as a way to predict pregnancy complications.

Why a Small DNA Signal Doesn't Rule Out Past Damage

Current egg output is an imperfect guide to accumulated injury. In schoolchildren studied across six African countries, school-level categories based on heavy infection did not consistently distinguish the prevalence of intestinal and liver-related illness. A separate Ugandan study found that age was more consistently associated with several measures of illness than current egg counts, but it did not establish age as a predictor of liver scarring.

Those studies measured eggs and other infection markers, not this stool qPCR assay. Their practical implication is that infection detection and assessment of organ damage are separate questions. A small DNA signal or a later negative result cannot exclude damage from an earlier infection.

When Results Can Be Misleading

• Early infection: immature worms may not yet be producing eggs, so a negative stool result soon after exposure can miss infection. There is no universal week at which every stool qPCR becomes reliable.
• Low or irregular egg output: a small stool sample may contain too little DNA for detection. Infections with worms of only one sex also lack normal egg production.
• Species coverage or specimen mismatch: the assay must recognize the species involved. Urinary schistosomiasis can be missed by stool testing.
• Reaction inhibition and handling: substances in stool, unsuitable preservatives, poor DNA extraction, or transport problems can cause a false negative. Laboratory controls help identify some of these failures.
• Contamination or a weak signal: accidental introduction of target DNA can cause a false positive. A result near an assay's detection limit may not reproduce.
• Recent treatment: qPCR detects DNA without establishing whether its source is alive. Residual eggs or DNA may complicate interpretation, but prolonged positivity documented in blood PCR studies cannot be assumed to have the same duration in stool.

Results from different laboratories are not directly interchangeable. DNA targets, extraction methods, and reporting rules differ, and changing the extraction method alone has changed detection rates in studies. A Ct shift alone isn't a validated measure of cure, and there is no universal conversion from Ct to an egg count.

Interpreting Changes Over Time

A falling DNA signal can support a response to treatment when the same assay is used. A negative result means no target DNA was detected in that sample; it doesn't prove that all worms are gone or that earlier tissue injury has healed.